Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-27
1996-08-20
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 18, 546 68, A61K 3148, A61K 3144, C07D45712, C07D45702
Patent
active
055479588
ABSTRACT:
8.alpha.-acylamino ergolines are useful dopamine agonists.
REFERENCES:
patent: 2864822 (1958-12-01), Fornefeld et al.
patent: 4764517 (1988-08-01), Gull
patent: 4766128 (1988-08-01), Sauer et al.
patent: 4772610 (1988-09-01), Biere et al.
patent: 4791115 (1988-12-01), Habfliger
patent: 4826852 (1989-05-01), Haffer et al.
patent: 4950672 (1992-08-01), Habfliger
Nordmann et al, Helvetica Chem. Acta, vol. 69, pp. 246 to 250 (1986).
Stutz et al, Eur. J. Med Chem.-Chim.Ther, vol. 17, pp. 537-541 (1982).
Brumby Thomas
Loschmann Peter-Andreas
Sauer Gerhard
Turner Jonathan
Wachtel Helmut
Higel Floyd D.
Schering Aktiengesellschaft
LandOfFree
N-(8.alpha.-ergolinyl)-amides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(8.alpha.-ergolinyl)-amides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(8.alpha.-ergolinyl)-amides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2330928